---
title: "Cholic Acid - Cerebrotendinous Xanthomatosis"
sidebar: mydoc_sidebar
permalink: db02659-mesh-d019294-1.html
toc: false 
---


Path ID: `DB02659_MESH_D019294_1`
{% include image.html url="images/db02659-mesh-d019294-1.png" file="db02659-mesh-d019294-1.png" alt="db02659-mesh-d019294-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D019826 | cholic acid | Drug |
| UniProt:Q02318 | Sterol 26-hydroxylase, mitochondrial | Protein |
| MESH:D019294 | Cerebrotendinous Xanthomatosis | Disease |
| MESH:D004083 | Cholestanol | ChemicalSubstance |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Cholic Acid | PRODUCED BY | Sterol 26-Hydroxylase, Mitochondrial |
| Sterol 26-Hydroxylase, Mitochondrial | NEGATIVELY CORRELATED WITH | Cerebrotendinous Xanthomatosis |
| Sterol 26-Hydroxylase, Mitochondrial | DECREASES ABUNDANCE OF | Cholestanol |
| Cholestanol | CONTRIBUTES TO | Cerebrotendinous Xanthomatosis |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB02659](https://go.drugbank.com/drugs/DB02659)
  - [https://www.ncbi.nlm.nih.gov/books/NBK395578/](https://www.ncbi.nlm.nih.gov/books/NBK395578/)
